Immunitybio
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $38,285 | $32,061 | $26,425 | $16,517 |
Gross Profit | 41,854 | 27,933 | 26,289 | 16,459 |
EBITDA | -64,683 | -35,774 | -59,541 | -97,206 |
EBIT | -39,725 | -63,421 | -101,035 | |
Net Income | -61,944 | -67,253 | -92,555 | -129,646 |
Net Change In Cash | 38,285 | 32,061 | 26,425 | 16,517 |
Free Cash Flow | -70,378 | -68,907 | -80,827 | -87,026 |
Cash | 88,334 | 60,241 | 137,658 | 60,660 |
Basic Shares | 989,679 | 946,601 | 888,216 | 853,162 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $113,288 | $14,745 | $622 | $240 |
Gross Profit | 112,535 | 14,745 | 622 | 240 |
EBITDA | -256,027 | -264,433 | -478,663 | -351,881 |
EBIT | -281,987 | -497,175 | -370,141 | |
Net Income | -351,398 | -413,564 | -583,196 | -416,567 |
Net Change In Cash | 113,288 | 14,745 | 622 | 240 |
Cost of Revenue | -76,599 | |||
Free Cash Flow | -304,936 | -398,124 | -397,341 | -415,671 |
Cash | 88,334 | 143,428 | 265,453 | 104,641 |
Basic Shares | 919,863 | 700,443 | 508,636 | 399,900 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.06 |
2025-09-30 | -$0.07 |
2025-06-30 | -$0.10 |
